
C4 Therapeutics, Inc.
USD3.83
+0.25 (+6.98%)
CEO
Andrew J. Hirsch
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.60
Prev. Close
$3.58
Day Low
$3.60
Day High
$3.90
52W Low
$1.69
52W High
$5.17
Market Cap
$0.32B
Volume
3.19M
| 17 Dec 2025 |
| Barclays |
| Overweight |
| Overweight |
| maintain |
| 23 Sept 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 23 Sept 2025 | Barclays | Overweight | Overweight | maintain |
| 22 Sept 2025 | Stephens & Co. | Overweight | Overweight | maintain |
| 15 Sept 2025 | Stephens & Co. | Equal Weight | Overweight | upgrade |
| 19 Dec 2024 | Wells Fargo | Equal Weight | Overweight | upgrade |
| 6 Aug 2024 | BMO Capital | Outperform | Outperform | maintain |